GRINasdaqPharmaceutical PreparationsFiscal year ends December 31
GRI Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.45+0.07 (+5.07%)
Close on Oct 19, 2026
- Market cap
- $2.62M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jan 26, 2026 | 1-for-28 reverse | Earlier per-share figures multiplied by 28 |
| Feb 24, 2025 | 1-for-17 reverse | Earlier per-share figures multiplied by 17 |
| Jun 18, 2024 | 1-for-13 reverse | Earlier per-share figures multiplied by 13 |
| Jan 30, 2024 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Jan 29, 2024 | 1-for-7 reverse | Earlier per-share figures multiplied by 7 |
| Apr 24, 2023 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 21, 2023 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |